Related references
Note: Only part of the references are listed.Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5
Xing Feng et al.
AUTOPHAGY (2021)
p21-activated kinase 6 controls mitosis and hepatocellular carcinoma progression by regulating Eg5
Jiaojiao Zheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2021)
Clinical Evaluation of P21 Activated Kinase 1 (PAK1) Activation in Gliomas and Its Effect on Cell Proliferation
Akkanapally Venu et al.
CANCER INVESTIGATION (2021)
p21-activated kinase 4 promotes the progression of esophageal squamous cell carcinoma by targeting LASP1
Hui Huang et al.
MOLECULAR CARCINOGENESIS (2021)
Prognostic significance of PAK family kinases in acute myeloid leukemia
Liang Quan et al.
CANCER GENE THERAPY (2020)
A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis
Nanxi Geng et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
MicroRNA-140-5p inhibits the tumorigenesis of oral squamous cell carcinoma by targeting p21-activated kinase 4
Min Peng et al.
CELL BIOLOGY INTERNATIONAL (2020)
A computational approach to explore and identify potential herbal inhibitors for the p21-activated kinase 1 (PAK1)
Md Shahinozzaman et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
PB-10, a thiazolo[4,5-d] pyrimidine derivative, targets p21-activated kinase 4 in human colorectal cancer cells
Ruijuan Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Group II p21-activated kinase, PAK4, is needed for activation of focal adhesion kinases, MAPK, GSK3, and β-catenin in rat pancreatic acinar cells
Irene Ramos-Alvarez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
KPT-9274, an Inhibitor of PAK4 and NAMPT, Leads to Downregulation of mTORC2 in Triple Negative Breast Cancer Cells
Emma Cordover et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
Identification of Pak1 inhibitors using water thermodynamic analysis
Jayashree Biswal et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics
Yu-kun Li et al.
LIFE SCIENCES (2020)
PAK3 mutations responsible for severe intellectual disability and callosal agenesis inhibit cell migration
Kevin Duarte et al.
NEUROBIOLOGY OF DISEASE (2020)
Integration of hepatitis B virus DNA into p21-activated kinase 3 (PAK3) gene in HepG2.2.15 cells
Peng Ruan et al.
VIRUS GENES (2020)
Identification of a novel PAK1 inhibitor to treat pancreatic cancer
Jiaqi Wang et al.
ACTA PHARMACEUTICA SINICA B (2020)
P-21-activated kinase 1 contributes to tumor angiogenesis upon photodynamic therapy via the HIF-1α/VEGF pathway
Shuai Jiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Chemical evolution for taming the 'pathogenic kinase' PAK1
Hiroshi Maruta et al.
DRUG DISCOVERY TODAY (2020)
Discovery of 2,4-diaminopyrimidine derivatives targeting p21-activated kinase 4: Biological evaluation and docking studies
Qiaohua Qin et al.
ARCHIV DER PHARMAZIE (2020)
p21-Activated Kinases in Thyroid Cancer
Luis Bautista et al.
ENDOCRINOLOGY (2020)
Recognition of physiological phosphorylation sites by p21-activated kinase 4
Ashwin K. Chetty et al.
JOURNAL OF STRUCTURAL BIOLOGY (2020)
Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease Running title: Propolis against SARS-CoV-2 infection and COVID-19
Andresa Aparecida Berretta et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer
Dahong Yao et al.
THERANOSTICS (2020)
CDK12 and PAK2 as novel therapeutic targets for human gastric cancer
Hui Liu et al.
THERANOSTICS (2020)
P21 activated kinase signaling in cancer
Chetan K. Rane et al.
SEMINARS IN CANCER BIOLOGY (2019)
Pak1 gene functioned differentially in different BCR-ABL subtypes in leukemiagenesis and treatment response through STAT5 pathway
Yuanxin Ye et al.
LEUKEMIA RESEARCH (2019)
Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer
Vladislav Korobeynikov et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Pak2 kinase promotes cellular senescence and organismal aging
Jong-Sun Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cells
Hsing-Yu Wu et al.
CANCER LETTERS (2019)
Simultaneous Inhibition of BCR-ABL1 Tyrosine Kinase and PAK1/2 Serine/Threonine Kinase Exerts Synergistic Effect against Chronic Myeloid Leukemia Cells
Sylwia Flis et al.
CANCERS (2019)
Targeting PKCι-PAK1 in EGFR-mutation positive non-small cell lung cancer
Masaoki Ito et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Cyclic AMP-dependent protein kinase A and EPAC mediate VIP and secretin stimulation of PAK4 and activation of Na+,K+-ATPase in pancreatic acinar cells
Irene Ramos-Alvarez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)
PAK4 signaling in health and disease: defining the PAK4-CREB axis
So-Yoon Won et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenstrom Macroglobulinemia
Na Li et al.
CLINICAL CANCER RESEARCH (2019)
P21-activated kinase 4 in pancreatic acinar cells is activated by numerous gastrointestinal hormones/neurotransmitters and growth factors by novel signaling, and its activation stimulates secretory/growth cascades
Irene Ramos-Alvarez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)
Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor
Zhi-Lei Zhang et al.
GENE THERAPY (2018)
Loss of p21-activated kinase 1 (Pak1) promotes atrial arrhythmic activity
Jaime DeSantiago et al.
HEART RHYTHM (2018)
Inhibition of RhoA and mTORC2/Rictor by Fingolimod (FTY720) induces p21-activated kinase 1, PAK-1 and amplifies podosomes in mouse peritoneal macrophages
Wei Chen et al.
IMMUNOBIOLOGY (2018)
Podocyte-specific Rac1 deficiency ameliorates podocyte damage and proteinuria in STZ-induced diabetic nephropathy in mice
Zhimei Lv et al.
CELL DEATH & DISEASE (2018)
How Reactive are Druggable Cysteines in Protein Kinases?
Ernest Awoonor-Williams et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)
PAK2 Haploinsufficiency Results in Synaptic Cytoskeleton Impairment and Autism-Related Behavior
Yan Wang et al.
CELL REPORTS (2018)
Salmonella stimulates pro-inflammatory signalling through p21-activated kinases bypassing innate immune receptors
Hui Sun et al.
NATURE MICROBIOLOGY (2018)
The p21-activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration
Yanwen Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
p-21 Activated Kinase as a Molecular Target for Chemoprevention in Diabetes
Kyle Dammann et al.
GERIATRICS (2018)
Lymphotoxin β receptor signalling executes Helicobacter pylori-driven gastric inflammation in a T4SS-dependent manner
Raquel Mejias-Luque et al.
GUT (2017)
Structure, biochemistry, and biology of PAK kinases
Rakesh Kumar et al.
GENE (2017)
Targeting group I p21-activated kinases to control malignant peripheral nerve sheath tumor growth and metastasis
G. Semenova et al.
ONCOGENE (2017)
p21-activated protein kinase 1 induces the invasion of gastric cancer cells through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase-2
Liang-Hui Li et al.
ONCOLOGY REPORTS (2017)
Aberrant Rac1-cofilin signaling mediates defects in dendritic spines, synaptic function, and sensory perception in fragile X syndrome
Alexander Pyronneau et al.
SCIENCE SIGNALING (2017)
Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway
Zhanyu Wang et al.
ONCOTARGET (2017)
Aberrant Rac1-cofilin signaling mediates defects in dendritic spines, synaptic function, and sensory perception in fragile X syndrome
Alexander Pyronneau et al.
SCIENCE SIGNALING (2017)
Prognostic and Predictive Value of p21-activated Kinase 6 Associated Support Vector Machine Classifier in Gastric Cancer Treated by 5-fluorouracil/Oxaliplatin Chemotherapy
Yuming Jiang et al.
EBIOMEDICINE (2017)
The PI3K Pathway in Human Disease
David A. Fruman et al.
CELL (2017)
Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens
Simona John von Freyend et al.
PATHOGENS (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
P21 (Cdc42/Rac)-activated kinase 1 (pak1) is associated with cardiotoxicity induced by antihistamines
Jaesuk Yun et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Vaccinia virus dissemination requires p21-activated kinase 1
Luciana G. Andrade et al.
ARCHIVES OF VIROLOGY (2016)
Ivermectin induces PAK1-mediated cytostatic autophagy in breast cancer
Kui Wang et al.
AUTOPHAGY (2016)
The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling cascades and in the onset of early pancreatitis events
Bernardo Nuche-Berenguer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine
Dannel Yeo et al.
BMC CANCER (2016)
Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer
Nhi Huynh et al.
CANCER BIOLOGY & THERAPY (2016)
Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window
Joachim Rudolph et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition
Olga Villamar Cruz et al.
ONCOTARGET (2016)
Glaucarubinone inhibits colorectal cancer growth by suppression of hypoxia-inducible factor 1α and β-catenin via a p-21 activated kinase 1-dependent pathway
Nhi Huynh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Gastrointestinal hormones/neurotransmitters and growth factors can activate P21 activated kinase 2 in pancreatic acinar cells by novel mechanisms
Bernardo Nuche-Berenguer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain
Laura Civiero et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Pak2 Regulates Hematopoietic Progenitor Cell Proliferation, Survival, and Differentiation
Yi Zeng et al.
STEM CELLS (2015)
Kinase-independent role for CRAF-driving tumour radioresistance via CHK2
Sunil J. Advani et al.
NATURE COMMUNICATIONS (2015)
PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy
Jian Chen et al.
ONCOTARGET (2015)
Prognostic Significance of p21-activated Kinase 6 Expression in Patients with Clear Cell Renal Cell Carcinoma
Weisi Liu et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Discovery and the structural basis of a novel p21-activated kinase 4 inhibitor
Byung Jun Ryu et al.
CANCER LETTERS (2014)
Pak1 Is Required to Maintain Ventricular Ca2+ Homeostasis and Electrophysiological Stability Through SERCA2a Regulation in Mice
Yanwen Wang et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2014)
Tracing PAKs from GI inflammation to cancer
Kyle Dammann et al.
GUT (2014)
An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosis
Derek W. Morris et al.
HUMAN MOLECULAR GENETICS (2014)
Senescence-inducing stress promotes proteolysis of phosphoglycerate mutase via ubiquitin ligase Mdm2
Takumi Mikawa et al.
JOURNAL OF CELL BIOLOGY (2014)
p21-Activated kinase1 (Pak1) is a negative regulator of NADPH-oxidase 2 in ventricular myocytes
Jaime DeSantiago et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer
Chirine El-Baba et al.
MOLECULAR CANCER (2014)
Herbal Therapeutics that Block the Oncogenic Kinase PAK1: A Practical Approach towards PAK1-dependent Diseases and Longevity
Hiroshi Maruta
PHYTOTHERAPY RESEARCH (2014)
Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism
Joao Fadista et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3-and KIT-Driven Leukemogenesis
Anindya Chatterjee et al.
CELL REPORTS (2014)
PAK signalling during the development and progression of cancer
Maria Radu et al.
NATURE REVIEWS CANCER (2014)
A role for p21-activated kinase 7 in the development of gastric cancer
Jun Gu et al.
FEBS JOURNAL (2013)
TGFβ receptor I transactivation mediates stretch-induced Pak1 activation and CTGF upregulation in mesangial cells
Guang Chen et al.
JOURNAL OF CELL SCIENCE (2013)
PAK-PIX interactions regulate adhesion dynamics and membrane protrusion to control neurite outgrowth
Miguel Santiago-Medina et al.
JOURNAL OF CELL SCIENCE (2013)
HIV Nef, Paxillin, and Pak1/2 Regulate Activation and Secretion of TACE/ADAM10 Proteases
Jung-Hyun Lee et al.
MOLECULAR CELL (2013)
Group I and II mammalian PAKs have different modes of activation by Cdc42
Yohendran Baskaran et al.
EMBO REPORTS (2012)
p21-Activated kinase inhibitors: a patent review
James J. Crawford et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
MORC2 Signaling Integrates Phosphorylation-Dependent, ATPase-Coupled Chromatin Remodeling during the DNA Damage Response
Da-Qiang Li et al.
CELL REPORTS (2012)
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
Christy C. Ong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1
Gemma C. Carter et al.
VIROLOGY (2011)
Effective neurofibromatosis therapeutics blocking the oncogenic kinase PAK1
Hiroshi Maruta
DRUG DISCOVERIES AND THERAPEUTICS (2011)
A Functional Requirement for PAK1 Binding to the KH(2) Domain of the Fragile X Protein-Related FXR1
Evonne Say et al.
MOLECULAR CELL (2010)
Expression of active p21-activated kinase-1 induces Ca2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes
Katherine A. Sheehan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression
Xin-Ze Cai et al.
CANCER BIOLOGY & THERAPY (2009)
CXCL10 Impairs β Cell Function and Viability in Diabetes through TLR4 Signaling
Fabienne T. Schulthess et al.
CELL METABOLISM (2009)
Essential role for the Pak4 protein kinase in extraembryonic tissue development and vessel formation
Yanmei Tian et al.
MECHANISMS OF DEVELOPMENT (2009)
alpha Pix interacts with Helicobacter pylori CagA to induce IL-8 expression in gastric epithelial cells
Joo Weon Lim et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Knockdown of p21-activated Kinase 6 Inhibits Prostate Cancer Growth and Enhances Chemosensitivity to Docetaxel
Xingqiao Wen et al.
UROLOGY (2009)
ROCK, PAK, and Toll of synapses in Alzheimer's disease
Antero Salminen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
PAK1 interacts with β-catenin and is required for the regulation of the β-catenin signalling pathway by gastrins
Hong He et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
P21-activated kinase is required for mitotic progression and regulates Plk1
B. Maroto et al.
ONCOGENE (2008)
A RAC/CDC-42-Independent GIT/PIX/PAK Signaling Pathway Mediates Cell Migration in C-elegans
Mark Lucanic et al.
PLOS GENETICS (2008)
p21-activated kinase 1 promotes soluble mutant huntingtin self-interaction and enhances toxicity
Shouqing Luo et al.
HUMAN MOLECULAR GENETICS (2008)
Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice
Mansuo L. Hayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Early herpes simplex virus type 1 infection is dependent on regulated Rac1/Cdc42 signalling in epithelial MDCKII cells
Sven Hoppe et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Cbl escapes Cdc42-mediated inhibition by downregulation of the adaptor molecule βPix
M. H. H. Schmidt et al.
ONCOGENE (2006)
Signaling from MARK to tau: Regulation, cytoskeletal crosstalk, and pathological phosphorylation
T. Timm et al.
NEURODEGENERATIVE DISEASES (2006)
The PAK1 autoregulatory domain is required for interaction with NIK in Helicobacter pylori-induced NF-kappa B activation
M Neumann et al.
BIOLOGICAL CHEMISTRY (2006)
The GIT-associated kinase PAK targets to the centrosome and regulates Aurora-A
ZS Zhao et al.
MOLECULAR CELL (2005)
An essential role of Pak1 phosphorylation of SHARP in Notch signaling
RK Vadlamudi et al.
ONCOGENE (2005)
Functional interaction between β-catenin and FOXO in oxidative stress signaling
MAG Essers et al.
SCIENCE (2005)
PAK4 is activated via PI3K in HGF-stimulated epithelial cells
CM Wells et al.
JOURNAL OF CELL SCIENCE (2002)
p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells
F Li et al.
EMBO REPORTS (2002)